Pdp (68071 3527 9)
Gabapentin Capsule
Product Images NDC 68071-3527
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 68071-3527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Gabapenin 01)
Figure 1 (Gabapenin 02)
Mean Pain Score
The provided text appears to be a heading or title indicating the topic of "Mean Pain Score". The following text seems to suggest a timeline or structure related to a "d-Week Dose Titration Period" followed by a "4-Week Fixed Dose Period". It mentions two options for treatment: "Placebo" and "Gabapentin, 3,600 mg/day". However, the rest of the text is not legible, making it difficult to provide a complete description or analysis.*
Figure 2 (Gabapenin 03)
Figure 3 (Gabapenin 04)
This text appears to show a list of percentage values ranging from 0% to 100%. There are also some additional information about two studies labeled as "Study 1" and "Study 2" along with some percentages related to them. There are also some symbols "** p<0.01" and "** p<0.001" present in the text.*
Figure 4 (Gabapenin 05)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
